Important notice

Meds75+ – information regarding the use for persons aged 75+

Substances A-Z

  • Ez

  • Ezetimibum
    Used as "LIPID MODIFYING AGENTS"
    Class B
    There is a lack of research evidence, clinical experience or efficacy among older persons. For now, the research evidence of monotherapy is scarce.

  • Gu

  • Guaifenesinum
    Used as "COUGH AND COLD PREPARATIONS"
    Class B
    Lack of research evidence, clinical experience or efficacy.

  • Me

  • Melatoninum
    Used as "PSYCHOLEPTICS"
    Class B
    Lack of research evidence, clinical experience or efficacy among older persons. For short-term use only. Has less adverse effects than in benzodiazepines or similar drugs. Non-pharmacological treatments are primary in the treatment of insomnia.

  • Mi

  • Mirabegronum
    Used as "UROLOGICALS"
    Class B
    Lack of research evidence, clinical experience or efficacy among older persons. Elimination is reduced in renal insufficiency. Take interactions into account.

  • Na

  • Naloxoni hydrochloridum
    Used as "ANALGESICS"
    Class B
    There is a lack of research evidence, clinical experience or efficacy among older persons.

  • Ra

  • Racecadotrilum
    Used as "ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS"
    Class B
    There is a lack of research evidence, clinical experience or efficacy among older persons. For short-term use only.

  • Su

  • Sumatriptanum
    Used as "ANALGESICS"
    Class B
    Lack of research evidence, clinical experience or efficacy among older persons. Take into account adverse effects to the heart and the cardiovascular system. It is not known if renal insufficiency affects the dosage.

  • Ta

  • Tacrolimusum
    Used as "OTHER DERMATOLOGICAL PREPARATIONS"
    Class B
    Lack of research evidence, clinical experience or efficacy among older persons.

Icon explanation

Class A A (green): Suitable for the older persons. The medicinal substance can be used as in younger patients. Changes due to aging do not affect the dose or frequency of administration, and the adverse reaction profile is not different from that of younger patients.

Class B B (grey): There is little research evidence, practical experience or efficacy in older persons.

Class C C (yellow): Suitable for older persons, with specific cautions. The medicinal substance can be used by older persons, but the dose might either have to be reduced, or the frequency of administration decreased due to mild or moderate renal insufficiency or a significant risk of interactions or adverse reactions.

Class D D (red): Avoid use in older persons. Use is possible only in exceptional cases or on a one-off basis. Changes due to aging predispose older persons to adverse or dangerous reactions to the drug. The risk of adverse reactions typically exceeds the benefits.

Meds75+ data source is Finnish Medicines Agency Fimea (licensed under CC BY 4.0).
Data updated on Mar 30, 2021.